| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income (loss) | ||||||
-603,573 | -201,303 | 169,325 | 209,426 | |||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||
Gain from reduction of tax receivable agreement liability | ||||||
192,884 | 1,665 | 0 | - | |||
Depreciation and amortization | ||||||
207,235 | 137,403 | 45,936 | 33,016 | |||
Amortization of Levothyroxine Transition Agreement asset | ||||||
36,393 | 10,423 | 0 | - | |||
Unrealized foreign currency loss | ||||||
-7,342 | -18,582 | 30,823 | -12,162 | |||
Amortization of debt issuance costs | ||||||
6,000 | 6,000 | 5,000 | 3,000 | |||
Loss on extinguishment of debt | ||||||
0 | -20,000 | -2,532 | 0 | |||
Gain on sale of international business | ||||||
7,258 | -2,958 | -29,232 | 0 | |||
Intangible asset impairment charges | ||||||
172,781 | 47,074 | 0 | 0 | |||
Non-cash restructuring and asset-related charges | ||||||
12,459 | 11,295 | 0 | 0 | |||
Deferred tax benefit | ||||||
371,716 | -9,439 | 742 | 121 | |||
Stock-based compensation | ||||||
21,679 | 167,597 | 0 | 0 | |||
Inventory provision | ||||||
82,245 | 44,539 | 3,771 | 9,235 | |||
Other operating charges and credits, net | ||||||
-7,309 | 1,866 | -9,935 | -197 | |||
Changes in assets and liabilities: | ||||||
Trade accounts receivable, net | ||||||
132,726 | -89,084 | -35,255 | 122,482 | |||
Inventories | ||||||
20,393 | 42,021 | 31,826 | 42,587 | |||
Prepaid expenses, other current assets and other assets | ||||||
-38,870 | -8,775 | 25,305 | -2,042 | |||
Related party receivables | ||||||
939 | -10,928 | 5,485 | -307 | |||
Accounts payable, accrued expenses and other liabilities | ||||||
-10,257 | -53,547 | 18,105 | 6,265 | |||
Related party payables | ||||||
5,228 | -14,113 | 8,208 | 4,303 | |||
Net cash provided by (used in) operating activities | ||||||
1,705 | 250,230 | 234,187 | 115,060 | |||
Cash flows from investing activities: | ||||||
Purchases of property, plant and equipment | ||||||
47,181 | 83,088 | 94,771 | 122,756 | |||
Acquisition of intangible assets | ||||||
50,250 | 14,000 | 19,500 | 1,850 | |||
Acquisitions, net of cash acquired | ||||||
0 | 324,634 | 0 | 0 | |||
Proceeds from surrender of corporate owned life insurance | ||||||
43,017 | 0 | 0 | - | |||
Proceeds from sales of property, plant and equipment | ||||||
0 | 25,344 | 0 | 0 | |||
Proceeds from sale of international businesses, net of cash sold | ||||||
34,834 | 0 | 15,717 | 0 | |||
Net cash used in investing activities | ||||||
-19,580 | -396,378 | -98,554 | -124,606 | |||
Cash flows from financing activities: | ||||||
Payments of deferred financing costs and debt extinguishment costs | ||||||
0 | 54,955 | 5,026 | 6,506 | |||
Proceeds from issuance of debt | ||||||
0 | 1,325,383 | 250,000 | 225,000 | |||
Payments of principal on debt and capital leases | ||||||
27,000 | 617,051 | 13,625 | 11,137 | |||
Net (payments) borrowings on revolving credit line | ||||||
0 | -75,000 | 50,000 | -25,000 | |||
Payments of principal on financing obligation - related party | ||||||
- | - | - | 259 | |||
Proceeds from exercise of stock options | ||||||
1,400 | 3,797 | 0 | 0 | |||
Employee payroll tax withholding on restricted stock unit vesting | ||||||
926 | 0 | 0 | - | |||
Equity contributions | ||||||
0 | 27,742 | 40 | - | |||
Payments for equity | ||||||
- | - | - | 5 | |||
Capital contribution from non-controlling interest | ||||||
0 | 360 | -865 | -973 | |||
Acquisition of redeemable non-controlling interest | ||||||
0 | 11,775 | 0 | 0 | |||
Acquisition of non-controlling interest | ||||||
3,543 | 0 | 0 | - | |||
Tax distribution to non-controlling interest | ||||||
13,494 | 35,543 | 0 | 0 | |||
Distributions to members | ||||||
0 | 183,000 | 375,265 | 200,615 | |||
Payments of principal on financing lease - related party | ||||||
2,256 | - | - | - | |||
Repayment of related party notes | ||||||
0 | 92,042 | 0 | 0 | |||
Net cash provided by (used in) financing activities | ||||||
-45,833 | 287,675 | -95,015 | -19,495 | |||
Effect of foreign exchange rate on cash | ||||||
-2,249 | -670 | -242 | 1,481 | |||
Net increase (decrease) in cash, cash equivalents, and restricted cash | ||||||
-65,957 | 140,857 | 40,376 | -27,560 | |||
Supplemental disclosure of cash flow information: | ||||||
Cash paid for interest | ||||||
158,568 | 131,505 | 65,086 | 50,569 | |||
Cash (paid) received for income taxes, net | ||||||
10,255 | 34,952 | -5,780 | 4,922 | |||
Supplemental disclosure of non-cash investing and financing activity: | ||||||
Tax distribution to non-controlling interest | ||||||
0 | 13,412 | 0 | 0 | |||
Notes payable for acquisitions - related party | ||||||
0 | 0 | 14,758 | 0 | |||
Acquisition of non-controlling interest | ||||||
0 | 3,485 | 0 | 0 | |||
Receivable from the sale of international business | ||||||
0 | 0 | 1,936 | 0 | |||
Transaction costs paid by Amneal Holdings | ||||||
0 | 0 | 8,561 | 0 | |||
Related Party | ||||||
Payments of principal on financing obligation - related party | ||||||
0 | 243 | 274 | - | |||
Payments of principal on financing lease - related party | ||||||
2,270 | 0 | 0 | - | |||